87 related articles for article (PubMed ID: 8355521)
1. Endothelial transdifferentiated phenotype and cell-cycle kinetics of AIDS-associated Kaposi sarcoma cells.
Way DL; Witte MH; Fiala M; Ramirez G; Nagle RB; Bernas MJ; Dictor M; Borgs P; Witte CL
Lymphology; 1993 Jun; 26(2):79-89. PubMed ID: 8355521
[TBL] [Abstract][Full Text] [Related]
2. Correlation between AIDS-related Kaposi sarcoma histological grade and in vitro behavior: reduced exogenous growth factor requirements for isolates from high grade lesions.
Bailer RT; Lazo A; Ng-Bautista CL; Hout BL; Ness GM; Hegtvedt AK; Lantry LE; Blakeslee JR; Stephens RE; Brierley GP
Lymphology; 1995 Sep; 28(3):126-37. PubMed ID: 7475261
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture.
Kaaya EE; Parravicini C; Ordonez C; Gendelman R; Berti E; Gallo RC; Biberfeld P
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):295-305. PubMed ID: 7552491
[TBL] [Abstract][Full Text] [Related]
4. Histogenesis of Kaposi's sarcoma associated with AIDS: a histologic, immunohistochemical and enzyme histochemical study.
Hashimoto H; Müller H; Falk S; Stutte HJ
Pathol Res Pract; 1987 Oct; 182(5):658-68. PubMed ID: 3684778
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E
Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
8. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma.
Pammer J; Plettenberg A; Weninger W; Diller B; Mildner M; Uthman A; Issing W; Stürzl M; Tschachler E
Am J Pathol; 1996 May; 148(5):1387-96. PubMed ID: 8623911
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukin-6 receptors and NF-kappa B in AIDS-related Kaposi sarcoma cell strains.
Bailer RT; Ng-Bautista CL; Ness GM; Mallery SR
Lymphology; 1997 Jun; 30(2):63-76. PubMed ID: 9215976
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma.
Varricchio F; Husain SR; Leland P; Gill P; Puri RK
Oncol Res; 1997; 9(9):495-503. PubMed ID: 9495455
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts.
Samaniego F; Young D; Grimes C; Prospero V; Christofidou-Solomidou M; DeLisser HM; Prakash O; Sahin AA; Wang S
Cell Growth Differ; 2002 Aug; 13(8):387-95. PubMed ID: 12193477
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic AIDS-associated Kaposi's sarcoma cell line KSY-1 cannot transdifferentiate into capillaries.
Lunardi-Iskandar Y; Wernert N; Cong TH; Samnang S; Bryant JL; Vandenbunder B; Stéhelin D
J Hum Virol; 1999; 2(5):315-7. PubMed ID: 10551738
[TBL] [Abstract][Full Text] [Related]
16. Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis.
Mallery SR; Bailer RT; Hohl CM; Ng-Bautista CL; Ness GM; Livingston BE; Hout BL; Stephens RE; Brierley GP
J Cell Biochem; 1995 Nov; 59(3):317-28. PubMed ID: 8567750
[TBL] [Abstract][Full Text] [Related]
17. AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens.
Scully PA; Steinman HK; Kennedy C; Trueblood K; Frisman DM; Voland JR
Am J Pathol; 1988 Feb; 130(2):244-51. PubMed ID: 3341448
[TBL] [Abstract][Full Text] [Related]
18. AIDS, Kaposi sarcoma, and the lymphatic system: update and reflections.
Witte MH; Witte CL; Way DL; Fiala M
Lymphology; 1990 Jun; 23(2):73-80. PubMed ID: 2214866
[TBL] [Abstract][Full Text] [Related]
19. Exogenous fibroblast growth factor-2 induces a transformed phenotype in vascular kaposi's sarcoma-like cells.
Cavallaro U; Soria MR; Montesano R
Mol Cell Biol Res Commun; 2000 Oct; 4(4):203-5. PubMed ID: 11409912
[TBL] [Abstract][Full Text] [Related]
20. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment.
Dezube BJ; Pantanowitz L; Aboulafia DM
AIDS Read; 2004 May; 14(5):236-8, 243-4, 251-3. PubMed ID: 15199854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
